SURUNKALI BEL OG‘RIG‘IDA RESTORATIV NEYROSTIMULYATSIYANING STATSIONAR VA AMBULATORIYA SHAROITLARIDA QO‘LLANILISHI: XALQARO TAJRIBALAR VA KLINIK NATIJALAR

Rinat Amenov

Jamoat salomatligi va Sog‘liqni saqlashni boshqarish: reabilitatsiya va jismoniy faoliyat yo’nalishi magistr talabasi

Guzal Sobirova

Reabilitologiya, xalq tabobati va jismoniy tarbiya kafedrasi o‘qituvchisi

Keywords: restorativ neyrostimulyatsiya; ReActiv8 tizimi; statsionar sharoit; ambulatoriya sharoit; klinik natijalar; multifidus mushaklari; xalqaro tajribalar; og‘riqni boshqarish; neuromodulyatsiya; Oswestry Disability Index; EQ-5D-5L; opioid qaramligi; implantatsiya; klinik sinovlar; ReActiv8-B sinovi; ReActiv8-RESTORE; hayot sifati; mushak tiklanishi; jarrohlik aralashuvi.

---

Abstract

Surunkali bel og‘rig‘i (SBO) butun dunyo bo‘ylab millionlab odamlarni ta’sir qiluvchi, sog‘liqni saqlash tizimiga katta yuk yuklaydigan va iqtisodiy zararlar keltiradigan eng dolzarb muammolardan biri hisoblanadi. Ushbu kasallik hayot sifatini sezilarli darajada pasaytiradi, ish qobiliyatini cheklaydi va ko‘pincha nogironlikka olib keladi. Ushbu maqolada restorativ neyrostimulyatsiya (RN), xususan ReActiv8 tizimi, SBO bilan og‘rigan bemorlarda statsionar (kasalxonada) va ambulatoriya (uy sharoitida) sharoitlarida qo‘llanilishi batafsil ko‘rib chiqiladi. Tadqiqot maqsadi - xalqaro klinik tajribalarni, jumladan ReActiv8-B, ReActiv8-A va ReActiv8-RESTORE sinovlarini tahlil qilish orqali RN ning samaradorligi, xavfsizligi, uzoq muddatli natijalari va bemorlarning hayot sifatini yaxshilashdagi rolini baholashdir. Adabiyotlar tahlili va klinik sinovlar ma’lumotlariga asoslanib, RN multifidus mushaklarini tiklash orqali og‘riqni 50-80% ga kamaytirishi, Oswestry Disability Index (ODI) ko‘rsatkichlarini 15-25 punktga yaxshilashi, EQ-5D-5L hayot sifati ko‘rsatkichlarini oshirishi va opioid dori vositalarining ishlatilishini 60-80% ga qisqartirishi ko‘rsatilgan. Statsionar sharoitlarda RN tez tiklanishni ta’minlaydi, chunki implantatsiya jarrohlik yo‘li bilan amalga oshiriladi va dastlabki monitoring kasalxonada o‘tkaziladi, bu esa infeksiya va asoratlar xavfini minimallashtiradi. Ambulatoriya sharoitlarda esa uzoq muddatli monitoring va o‘z-o‘zini nazorat qilish imkoniyati mavjud bo‘lib, bu bemorlarning kundalik hayotiga moslashishini osonlashtiradi. Xalqaro tajribalar, jumladan AQSh, Yevropa Ittifoqi, Avstraliya va Osiyo mamlakatlaridagi klinik sinovlar natijalari RN ning SBO davolashda yangi paradigma ekanligini tasdiqlaydi, ammo qimmatligi, implantatsiya xavfi va individual bemor xususiyatlariga bog‘liq cheklovlar mavjud. Ushbu yondashuv bemorlarning hayot sifatini oshirishda, nogironlikni kamaytirishda va sog‘liqni saqlash xarajatlarini optimallashtirishda muhim rol o‘ynashi mumkin. Maqola natijalari klinik amaliyot uchun tavsiyalar beradi va kelajakdagi tadqiqotlar uchun yo‘nalishlarni belgilaydi, masalan, RN ning boshqa neuromodulyatsiya usullari bilan taqqoslanishi va uzoq muddatli (5-10 yillik) natijalarini o‘rganish.

---

References

1. Thomson, S., Chawla, R., Love-Jones, S., Sharma, M., Vajramani, G., Williams, A., & Eldabe, S. (2021). Restorative neurostimulation for chronic mechanical low back pain: Results from a prospective multi-centre longitudinal cohort. Pain and Therapy, 10(2), 1451–1465. https://doi.org/10.1007/s40122-021-00307-3

2. Amann, M., & Ardeshiri, A. (2024). Application of restorative neurostimulation for chronic mechanical low back pain in an older population with 2-year follow-up: Aggregate analysis of three independent studies. Regional Anesthesia & Pain Medicine. Advance online publication. https://doi.org/10.1136/rapm-2023-105032

3. Thomson, S., Williams, A., Vajramani, G., Sharma, M., Love-Jones, S., Chawla, R., & Eldabe, S. (2023). Restorative neurostimulation for chronic mechanical low back pain – Three year results from the United Kingdom post market clinical follow-up registry. British Journal of Pain, 17(5), 447–456. https://doi.org/10.1177/20494637231181498

4. Deckers, K., De Smedt, K., Mitchell, B., Gentile, J., & Eldabe, S. (2022). PO235 / #718 Restorative neurostimulation for chronic mechanical low back pain – 1-year results from the restore study. Neuromodulation: Technology at the Neural Interface, 25(4, Supplement), S121. https://doi.org/10.1016/j.neurom.2022.02.182

5. Gilligan, C. J., Chavda, A. S., Ho, J. S., Lee, D. W., Langhorst, M., Yih, E. T., & Amann, M. (2025). Restorative neurostimulation for patients with mechanical chronic low back pain and impaired neuromuscular control of the lumbar spine: A new treatment paradigm. Journal of Pain Research, 18, 5799–5813. https://doi.org/10.2147/JPR.S525057

6. International Society for the Advancement of Spine Surgery. (2023). International Society for the Advancement of Spine Surgery Statement: Restorative neurostimulation for chronic mechanical low back pain resulting from neuromuscular instability. International Journal of Spine Surgery, 17(5), 728–750. https://doi.org/10.14444/8525

7. Thomson, S., Williams, A., Vajramani, G., Sharma, M., Love-Jones, S., Chawla, R., & Eldabe, S. (2025). 5-year longitudinal follow-up of patients treated for chronic mechanical low back pain using restorative neurostimulation. Regional Anesthesia & Pain Medicine. Advance online publication. https://doi.org/10.1136/rapm-2025-106899

8. Gilligan, C., Volschenk, W., Russo, M., Green, M., Gilmore, C., Mehta, V., Deckers, K., De Smedt, K., Latif, U., Georgius, P., Gentile, J., Mitchell, B., Langhorst, M., Huygen, F., Baranidharan, G., Patel, V., Mironer, E., Ross, E., Carayannopoulos, A., Hayek, S., Gulve, A., Van Buyten, J.-P., Tohmeh, A., Fischgrund, J., Lad, S., Ahadian, F., Deer, T., Klemme, W., Rauck, R., Rathmell, J., Levy, R., Heemels, J. P., Eldabe, S., & ReActiv8-B Investigators. (2021). An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: A randomized sham-controlled clinical trial. Pain, 162(10), 2486–2498. https://doi.org/10.1097/j.pain.0000000000002258

9. Gilligan, C., Volschenk, W., Russo, M., Green, M., Gilmore, C., Mehta, V., Deckers, K., De Smedt, K., Latif, U., Georgius, P., Mitchell, B., Langhorst, M., Huygen, F., Baranidharan, G., Patel, V., Gulve, A., Van Buyten, J. P., Tohmeh, A., Fischgrund, J., Ahadian, F., Deer, T., Klemme, W., Rauck, R., Rathmell, J., Schwab, F., Maislin, G., Heemels, J. P., Eldabe, S., & ReActiv8-B Investigators. (2023). Long-term outcomes of restorative neurostimulation in patients with refractory chronic low back pain secondary to multifidus dysfunction: Two-year results of the ReActiv8-B pivotal trial. Neuromodulation: Technology at the Neural Interface, 26(1), 98–107. https://doi.org/10.1016/j.neurom.2021.10.011

10. Gilligan, C., Volschenk, W., Russo, M., Gilmore, C., Mehta, V., De Smedt, K., Latif, U., Georgius, P., Gentile, J., Mitchell, B., Langhorst, M., Huygen, F., Baranidharan, G., Patel, V., Gulve, A., Van Buyten, J. P., Tohmeh, A., Fischgrund, J., Ahadian, F., Deer, T., Klemme, W., Rauck, R., Rathmell, J., Schwab, F., Maislin, G., Heemels, J. P., Eldabe, S., & ReActiv8-B Investigators. (2022). Three-year durability of restorative neurostimulation effectiveness in patients with chronic low back pain and multifidus muscle dysfunction. Neuromodulation: Technology at the Neural Interface, 25(7), 987–995. https://doi.org/10.1016/j.neurom.2022.08.457

11. Thomson, S., Chawla, R., Love-Jones, S., Sharma, M., Vajramani, G., Williams, A., & Eldabe, S. (on behalf of The ReActiv8 PMCF Investigators). (2021). Restorative neurostimulation for chronic mechanical low back pain: Results from a prospective multi-centre longitudinal cohort. Pain and Therapy, 10(2), 1451–1465. https://doi.org/10.1007/s40122-021-00307-3

12. Gilligan, C., Volschenk, W., Russo, M., Gilmore, C., Mehta, V., De Smedt, K., Latif, U., Georgius, P., Gentile, J., Mitchell, B., Langhorst, M., Huygen, F., Baranidharan, G., Patel, V., Gulve, A., Van Buyten, J. P., Tohmeh, A., Fischgrund, J., Ahadian, F., Deer, T., Klemme, W., Rauck, R., Rathmell, J., Schwab, F., Maislin, G., Heemels, J. P., Eldabe, S., & ReActiv8-B Investigators. (2022). Long-term outcomes of restorative neurostimulation in patients with refractory mechanical chronic low back pain: 2-year results of the ReActiv8-B randomized controlled trial. Neuromodulation: Technology at the Neural Interface, 25(1), S1–S10. https://doi.org/10.1016/j.neurom.2021.10.018

13. Florida Spine Associates. (2025, March 10). ReActiv8: A breakthrough for lower back pain. https://floridaspineassociates.com/2025/03/10/reactiv8-a-breakthrough-for-lower-back-pain/

14. ClinicalTrials.gov. (2021). ReActiv8 stimulation therapy vs optimal medical management: A randomized evaluation (RESTORE). Identifier NCT04803214. https://clinicaltrials.gov/study/NCT04803214

15. Amann, M., & Ardeshiri, A. (2024). Restorative neurostimulation for chronic low back pain using an implantable neurostimulator: A case report. Interventional Pain Medicine, 3(2), 100403. https://doi.org/10.1016/j.inpm.2024.100403

16. OrthoSpineNews. (2025, January 16). Mainstay Medical announces positive results from the landmark ReActiv8 restore clinical trial. https://orthospinenews.com/2025/01/16/mainstay-medical-announces-positive-results-from-the-landmark-reactiv8-restore-clinical-trial/

17. Schwab, F., Gilligan, C., Mekhail, N., Patel, K., Maislin, G., Levy, R., Rathmell, J., & Schwab, F. (2025). Restorative neurostimulation therapy compared to optimal medical management: A randomized evaluation (RESTORE) for the treatment of chronic mechanical low back pain due to multifidus dysfunction. Pain and Therapy. Advance online publication. https://doi.org/10.1007/s40122-024-00689-0

18. Mainstay Medical. (n.d.). What is ReActiv8? https://mainstaymedical.com/what-is-reactiv8/